Phase 4 Immunosuppression Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Combined Immunosuppression for Pediatric Crohn's Disease
Crohn DiseaseImmunosuppressionChildren, Only+1 more
Children's Hospital of Fudan University128 enrolled1 locationNCT05043870
Recruiting
Phase 4
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Liver TransplantationImmunosuppression
University Hospital, Limoges162 enrolled18 locationsNCT06354179
Recruiting
Phase 4
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Kidney Disease, ChronicImmunosuppressionTransplant Recipient (Kidney)
Instituto de Investigación Hospital Universitario La Paz114 enrolled1 locationNCT06701825
Recruiting
Phase 4
Immunoinflammatory Regulation of Esketamine in Septic Patients
SepsisInflammatory ResponseEsketamine+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology100 enrolled2 locationsNCT04843982
Recruiting
Phase 4
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
COVID-19ImmunosuppressionVaccine Response Impaired
University of California, Davis50 enrolled1 locationNCT05060991
Recruiting
Phase 4
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Immunosuppression
Edward Geissler300 enrolled9 locationsNCT06268769
Recruiting
Phase 4
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
Heart FailureMyocarditisImmunosuppression+2 more
Medical University of Warsaw100 enrolled1 locationNCT04654988
Recruiting
Phase 4
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Liver TransplantationImmunosuppression
University of British Columbia124 enrolled1 locationNCT05089604